INTELLIGENT BIO SOLUTIONS INC. current report, 17 March 2022

Business Context and Reporting Period

This Form 8-K was filed by GBS Inc. (trading symbol: GBS) on March 22, 2022, reporting an event that occurred on March 17, 2022. The company is incorporated in Delaware and its common stock is listed on The NASDAQ Stock Market LLC. The filing addresses a regulatory notice regarding the company's compliance with Nasdaq listing standards.

Key Financial Metrics

The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on the status of the company's stock price relative to listing requirements.

Material Changes

The primary material event reported is the receipt of a notice from Nasdaq indicating that the company's common stock closing bid price fell below $1.00 for 30 consecutive business days. This constitutes a failure to meet Nasdaq Listing Rule 5450(a)(1). There is no immediate effect on the listing or trading of the stock.

Outlook, Risks, and Contingencies

  • Compliance Period: The company has been granted an initial 180-day compliance period, ending September 13, 2022, to regain compliance.
  • Remediation Path: Compliance can be achieved if the closing bid price reaches at least $1.00 for 10 consecutive business days during the compliance period.
  • Secondary Compliance Period: If the initial period expires without compliance, the company may be eligible for an additional 180-day period. This requires submitting a transfer application, meeting market value standards, and potentially effecting a reverse stock split.
  • Delisting Risk: If the company fails to cure the deficiency or does not submit the required application for the second period, Nasdaq will issue a notice of delisting.

Investor Verification Checklist

  • Verify the current closing bid price of GBS stock to assess progress toward the $1.00 threshold.
  • Monitor company announcements regarding the potential implementation of a reverse stock split.
  • Check for any subsequent correspondence from Nasdaq regarding the status of the compliance period.
  • Review the company's market value of publicly held shares to ensure it meets the initial listing standards required for a potential second compliance period.